CAS: 68039-19-0 - α-d-Glucopyranosiduronic acid, (3β,20β)-20-carboxy-11-oxo-30-norolean-12-en-3-yl 2-O-β-d-glucopyranuronosyl-, potassium salt

Formule : C₄₂H₆₂O₁₆・xK

InChI : InChI=1S/C42H62O16.K/c1-37(2)21-8-11-42(7)31(20(43)16-18-19-17-39(4,36(53)54)13-12-38(19,3)14-15-41(18,42)6)40(21,5)10-9-22(37)55-35-30(26(47)25(46)29(57-35)33(51)52)58-34-27(48)23(44)24(45)28(56-34)32(49)50;/h16,19,21-31,34-35,44-48H,8-15,17H2,1-7H3,(H,49,50)(H,51,52)(H,53,54);/t19-,21-,22-,23-,24-,25-,26-,27+,28-,29-,30+,31+,34-,35-,38+,39-,40-,41+,42+;/m0./s1

Code InChI : InChIKey=XCZIARIJVDURGH-OOFFSTKBSA-N

SMILES : [K].O=C(O)C1OC(OC2C(OC(C(=O)O)C(O)C2O)OC3CCC4(C)C5C(=O)C=C6C7CC(C(=O)O)(C)CCC7(C)CCC6(C)C5(C)CCC4C3(C)C)C(O)C(O)C1O

Synonymes :

• 30-Noroleanane, α-<span class="text-smallcaps">D</span>-glucopyranosiduronic acid deriv.
• Glycyrrhizinic acid, potassium salt
• Potassium glycyrrhizinate
• alpha-D-Glucopyranosiduronic acid, (3beta,20beta)-20-carboxy-11-oxo-30-norolean-12-en-3-yl 2-O-beta-D-glucopyranuronosyl-, potassium salt
• alpha-D-Glucopyranosiduronic acid, (3beta,20beta)-20-carboxy-11-oxo-30-norolean-12-en-3-yl 2-O-beta-D-glucopyranuronosyl-, potassium salt (1:?)
• alpha-D-Glucopyranosiduronic acid, (3beta,20beta)-20-carboxy-11-oxo-30-norolean-12-en-3-yl 2-O-beta-D-glucopyranuronosyl-, potassiumsalt
• α-<span class="text-smallcaps">D</smallcap>-Glucopyranosiduronic acid, (3β,20β)-20-carboxy-11-oxo-30-norolean-12-en-3-yl 2-O-β-<smallcap>D</span>-glucopyranuronosyl-, potassium salt
• α-<span class="text-smallcaps">D</smallcap>-Glucopyranosiduronic acid, (3β,20β)-20-carboxy-11-oxo-30-norolean-12-en-3-yl 2-O-β-<smallcap>D</span>-glucopyranuronosyl-, potassium salt (1:?)

Glycyrrhizinic acid, potassium salt

CAS : 68039-19-0

Glycyrrhizinic acid, potassium salt can reduce ventricular arrhythmias caused by veratrol

• Formule : C₄₂H₆₁KO₁₆
• Degré de pureté : 98%
• Couleur et forme : Solid
• Masse moléculaire : 861.02